Peyman Hadji

9.3k citations
167 papers · 5.8k indexed · 2 hit papers · h-index 37
Topics
Bone health and treatments (93 papers)Estrogen and related hormone effects (58 papers)Bone health and osteoporosis research (45 papers)

In The Last Decade

Peyman Hadji

155 papers receiving 5.6k citations

Hit Papers

Bone health in cancer patients: ESMO Clinical Practice Gu...201420262018202220142020100200300400

Peers

Peyman Hadji
Comparison fields: 5 of 125
  • Oncology 3.9k
  • Orthopedics and Sports Medicine 1.7k
  • Genetics 1.2k
  • Molecular Biology 1.1k
  • Pulmonary and Respiratory Medicine 936
Replace Bent Ejlertsen with:
Bent Ejlertsen Denmark
Holly Anderson United States
Simon Cawthorn United Kingdom
Tiina Saarto Finland
Matthew R. Smith United States
Mark Clemons Canada
Tracy Wang United States
S. Ashley United Kingdom
Katia Tonkin Canada
J S Tobias United Kingdom
Peyman Hadji relative to Bent Ejlertsen Denmark Bent Ejlertsen's profile →
Citations per field
00.5×10×12.8×
Bent Ejlertsen · 1×
Citations per year

Countries citing papers authored by Peyman Hadji

Since Specialization
Citations

This map shows the geographic impact of Peyman Hadji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peyman Hadji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peyman Hadji more than expected).

Fields of papers citing papers by Peyman Hadji

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peyman Hadji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peyman Hadji. The network helps show where Peyman Hadji may publish in the future.

Co-authorship network of co-authors of Peyman Hadji

This figure shows the co-authorship network connecting the top 25 collaborators of Peyman Hadji. A scholar is included among the top collaborators of Peyman Hadji based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peyman Hadji. Peyman Hadji is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1
Bone health in cancer: ESMO Clinical Practice Guidelinesbreakdown →
294
2 45
3 33
4 73
5
Evolution of subject characteristics in FREEDOM and its extension for up to 8 years
2
6 11
7 43
8 26
9 12
10 77
11 73
12 21
13 1
14 264
15 220
16 65
17 436
18
Monthly ibandronate improves persistence vs. weekly bisphosphonates after 9 months of treatment
1
19 3
20 40

About Peyman Hadji

Peyman Hadji is a scholar working on Orthopedics and Sports Medicine, Oncology and Family Practice, having authored 167 papers that have together received 5.8k indexed citations. Recurring topics across this work include Bone health and treatments (93 papers), Estrogen and related hormone effects (58 papers) and Bone health and osteoporosis research (45 papers). The work is most often cited by research in Orthopedics and Sports Medicine (1.7k citations), Family Practice (381 citations) and Oncology (3.9k citations). Peyman Hadji has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Robert E. Coleman, Matti Aapro, Jean‐Jacques Body, Matthias Kalder, Michael Gnant, Volker Ziller, Allan Lipton, Jørn Herrstedt, Ioannis Kyvernitakis and Lorenz C. Hofbauer. Their work appears in journals such as The Lancet, JAMA and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026